<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><description>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！ 投稿请发：442015666@qq.com 推广合作请联系：15057280775/15858667450</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 30 May 2021 14:43:26 +0800</pubDate><image><url>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</url><title>药事纵横 | wechat-feeds</title><link>http://MzUxOTgxNzg4NA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>实例教你如何完成原料药中元素杂质的风险评估报告</title><link>https://mp.weixin.qq.com/s/waM7pZeSj-iXCb2fZQRp1g</link><description></description><content:encoded><![CDATA[实例教你如何完成原料药中元素杂质的风险评估报告]]></content:encoded><pubDate>Sat, 29 May 2021 19:54:03 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/MXpikG8T-rj-DE0apf1wBQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Sat, 29 May 2021 19:54:03 +0800</pubDate></item><item><title>日程首发 | 第一届改良型新药趋势及技术峰会</title><link>https://mp.weixin.qq.com/s/vakC2wouBPDIDf7v0KCrvw</link><description></description><content:encoded><![CDATA[日程首发 | 第一届改良型新药趋势及技术峰会]]></content:encoded><pubDate>Sat, 29 May 2021 19:54:03 +0800</pubDate></item><item><title>2021.05.27药品批件信息！9个药品通过一致性评价</title><link>https://mp.weixin.qq.com/s/nyRiiI4O6OLVf0fSdFhAtg</link><description></description><content:encoded><![CDATA[2021.05.27药品批件信息！9个药品通过一致性评价]]></content:encoded><pubDate>Sat, 29 May 2021 19:54:03 +0800</pubDate></item><item><title>安进（Amgen）2021：KRAS提交上市申请；新药布局潜力巨大</title><link>https://mp.weixin.qq.com/s/QY_AUbDmUKPpzKHSLm6aLQ</link><description></description><content:encoded><![CDATA[安进（Amgen）2021：KRAS提交上市申请；新药布局潜力巨大]]></content:encoded><pubDate>Sat, 29 May 2021 19:54:03 +0800</pubDate></item><item><title>2021版日本制药企业销售排名Top43</title><link>https://mp.weixin.qq.com/s/2ArmIWveMwaLFooLWCcNIQ</link><description></description><content:encoded><![CDATA[2021版日本制药企业销售排名Top43]]></content:encoded><pubDate>Fri, 28 May 2021 22:34:51 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/hMdIqUGgLMoPjoNuYisQXQ</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Fri, 28 May 2021 22:34:51 +0800</pubDate></item><item><title>5.17-5.23公示56项临床试验，涉及罗氏、恒瑞、君实等32款新药</title><link>https://mp.weixin.qq.com/s/FFcGv2a14jtXQ2jG7-yDHw</link><description></description><content:encoded><![CDATA[5.17-5.23公示56项临床试验，涉及罗氏、恒瑞、君实等32款新药]]></content:encoded><pubDate>Fri, 28 May 2021 22:34:51 +0800</pubDate></item><item><title>中科院上海药物所苏研院——国内领先的药物研发平台</title><link>https://mp.weixin.qq.com/s/GQBhlE2v3lTT2ZF_DWwo2w</link><description></description><content:encoded><![CDATA[中科院上海药物所苏研院——国内领先的药物研发平台]]></content:encoded><pubDate>Fri, 28 May 2021 22:34:51 +0800</pubDate></item><item><title>NMPA发布：执业药师电子注册证来了，长这样！</title><link>https://mp.weixin.qq.com/s/3obGQasqTkxz9TylM_7SSw</link><description></description><content:encoded><![CDATA[NMPA发布：执业药师电子注册证来了，长这样！]]></content:encoded><pubDate>Fri, 28 May 2021 22:34:51 +0800</pubDate></item><item><title>仿制药步履维艰，创新药高风险，药企怎么办？</title><link>https://mp.weixin.qq.com/s/KUXfohle0E-79GKO4h-Yng</link><description></description><content:encoded><![CDATA[仿制药步履维艰，创新药高风险，药企怎么办？]]></content:encoded><pubDate>Thu, 27 May 2021 17:05:55 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/1WaWlPoHlubhyK3SE-_X9w</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Thu, 27 May 2021 17:05:55 +0800</pubDate></item><item><title>中科院上海药物所苏研院——国内领先的药物研发平台</title><link>https://mp.weixin.qq.com/s/Yl356lWr9XnI2qfXNAiysQ</link><description></description><content:encoded><![CDATA[中科院上海药物所苏研院——国内领先的药物研发平台]]></content:encoded><pubDate>Thu, 27 May 2021 17:05:55 +0800</pubDate></item><item><title>最新！FDA发布双特异性抗体研发工业指南！</title><link>https://mp.weixin.qq.com/s/H6PSUNldBnAz2z3OF2hE1g</link><description></description><content:encoded><![CDATA[最新！FDA发布双特异性抗体研发工业指南！]]></content:encoded><pubDate>Thu, 27 May 2021 17:05:55 +0800</pubDate></item><item><title>重磅！国知局：仑伐替尼制剂专利无效，继晶型后</title><link>https://mp.weixin.qq.com/s/Af0MSm2BDj1Ez_lVduOoUQ</link><description></description><content:encoded><![CDATA[重磅！国知局：仑伐替尼制剂专利无效，继晶型后]]></content:encoded><pubDate>Thu, 27 May 2021 17:05:55 +0800</pubDate></item><item><title>二线CXO：何时突破500亿市值封锁</title><link>https://mp.weixin.qq.com/s/Wohsj7_VGq_hs2Ug3pSaWg</link><description></description><content:encoded><![CDATA[二线CXO：何时突破500亿市值封锁]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>风云汇聚姑苏城：万名医药人共画中国CMC-China</title><link>https://mp.weixin.qq.com/s/jWoOIO0AfLW5ZS0LGW9Gzg</link><description></description><content:encoded><![CDATA[风云汇聚姑苏城：万名医药人共画中国CMC-China]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会</title><link>https://mp.weixin.qq.com/s/pZwK-RvSQULS2uzsY_h9Aw</link><description></description><content:encoded><![CDATA[十余位原FDA/CDE/千人共话创新制剂及改良型新药峰会]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>2021.05.24药品批件信息！52个药品通过一致性评价</title><link>https://mp.weixin.qq.com/s/qyjem9PMYi3nlPf4sKVOZg</link><description></description><content:encoded><![CDATA[2021.05.24药品批件信息！52个药品通过一致性评价]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item><item><title>“酶”好时代来临：数家药企角逐助力绿色制药</title><link>https://mp.weixin.qq.com/s/BRRlTDitsQifv3AMOtHQjg</link><description></description><content:encoded><![CDATA[“酶”好时代来临：数家药企角逐助力绿色制药]]></content:encoded><pubDate>Wed, 26 May 2021 17:27:04 +0800</pubDate></item></channel></rss>